Diabetes: Secondary Complications, Regulation and Innovation

-

Join your peers at the only conference dedicated to the leading causes of mortality and morbidity in diabetes, this autumn, in London. Our distinguished faculty unite the fields of pharmacology, nanotechnology and clinical medicine to target atherosclerosis, endothelial inflammation and end-stage renal disease.

SMi's unique program brings together the latest research from those at the forefront of attenuating the complications arising from hyperglycaemia, dyslipidaemia, and angiopathy.

“This conference is an excellent one stop shop to up-skill on current issues in diabetes therapy. I’m happy to chair what will no doubt be a very stimulating session.” – Phil Ambery, Medical Director, GlaxoSmithKline

Key Reasons to Attend:
• Receive clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Remain abreast of new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study

Key Speakers Include:
• James F. List, Vice President and Full Development Lead, Dapagliflozin, Bristol-Myers Squibb
• John Wilding, Professor of Medicine & Honorary Consultant Physician, Head of Department of Obesity and Endocrinology, University of Liverpool Hospital
• Martin Siman, Director, Design and Interpretation Centre of Excellence, AstraZeneca
• Philip Ambery, Director, Clinical Development, GlaxoSmithKline
• Sandra Souza, Team Lead, Molecular Biomarkers, PPDM , Merck Sharp & Dohme

Diabetes: Secondary Complications, Regulation and Innovation, promises to be a unique platform for networking, problem solving and learning from timely case studies. This really is a unique event not to be missed.

Click here to find out more and/or book your place.


Location:
Marriott Hotel, Regents Park
UK
UK


Organizer: SMi Group Ltd

1 Oct 2013



All Upcoming Events
1 2 Next 
CYTO 201828 Apr 2018
PEGS: The Essential Protein Engineering Summit 201830 Apr 2018
ICMSEM 2018: 20th International Conference on Materials Science, Engineering and Manufacturing3 May 2018
Clinical Trial Innovation Summit 20187 May 2018
Bio-IT World 201815 May 2018
Injectable Drug Delivery 201815 May 2018
Highly Potent Active Pharmaceutical Ingredients (HPAPI) 201821 May 2018
SMi's Pain Therapeutics Conference 201821 May 2018
Molecular Diagnostics Europe22 May 2018
ASSET 201828 May 2018
2nd Annual High Potent Medicines Conference29 May 2018
3rd Annual Bioprocessing of Advanced Cellular Therapies Congress29 May 2018
Next-Gen Regenerative Medicine & Tissue Engineering Conference29 May 2018
Protein Design & Engineering Conference29 May 2018
66th ASMS Conference3 Jun 2018
Pre-Filled Syringes West Coast4 Jun 2018
ACHEMA 201811 Jun 2018
Pharmaceutical Freeze-Drying Technology 201812 Jun 2018
Biobanking 201813 Jun 2018
Microbiome Drug Development Summit20 Jun 2018
SLAS Europe 201827 Jun 2018
PREP 2018: 31st International Symposium and Exhibit on Preparative and Process Chromatography8 Jul 2018
HPLC 201829 Jul 2018
70th AACC Annual Scientific Meeting & Clinical Lab Expo29 Jul 2018
Clinical Research 201810 Sep 2018
17th International Symposium on Preparative and Industrial Chromatography and Allied Techniques7 Oct 2018
10th International Conference on Mass Spectrometry and Chromatography8 Oct 2018
17th International Conference on Pathology8 Oct 2018
3rd World Summit & Expo on Food Technology and Probiotics25 Oct 2018
3rd World Summit & Expo on Food Technology and Probiotics25 Oct 2018

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement